SHELBY PARSONS: Open Payments
NPI 1700351392 · SHAWNEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 58 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $450 |
| Novo Nordisk Inc | 8 | $142 |
| Lilly USA, LLC | 3 | $47 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: UBRELVY, VRAYLAR, Saxenda, SKYRIZI, MOUNJARO, Rybelsus, QULIPTA, RINVOQ.
Industry payments across OK — which companies pay providers there.
